Xrcc2 - X-ray repair cross complementing 2

Predicted to enable ATP binding activity and ATP-dependent activity, acting on DNA. Predicted to contribute to four-way junction DNA binding activity. Predicted to be involved in DNA recombination; centrosome cycle; and mitotic cell cycle. Predicted to act upstream of or within several processes, including chordate embryonic development; regulation of apoptotic process; and response to X-ray. Predicted to be located in nucleoplasm. Predicted to be part of Rad51B-Rad51C-Rad51D-XRCC2 complex. Predicted to be active in centrosome and replication fork. Human ortholog(s) of this gene implicated in Fanconi anemia complementation group U; pancreatic cancer; primary ovarian insufficiency 17; and spermatogenic failure 50. Orthologous to human XRCC2 (X-ray repair cross complementing 2). [provided by Alliance of Genome Resources, Apr 2022]